Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis

被引:45
作者
Antoniades, Charalambos [1 ]
Tousoulis, Dimitris [1 ]
Marinou, Kyriakoula [1 ]
Papageorgiou, Nikos [1 ]
Bosinakou, Erini [1 ]
Tsioufis, Costas [1 ]
Stefanadi, Elli [1 ]
Latsios, George [1 ]
Tentolouris, Costas [1 ]
Siasos, Gerasimos [1 ]
Stefanadis, Christodoulos [1 ]
机构
[1] Univ Athens, Sch Med, A Cardiol Dept, GR-10679 Athens, Greece
关键词
endothelium; inflammation; coronary artery disease; diabetes mellitus;
D O I
10.1002/clc.20101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 2 diabetes mellitus (T2DM) is characterized by endothelial dysfunction, increased thrombogeneisity and abnormal inflammatory response. Hypothesis: We hypothesizsed that insulin dependence/exogenous insulin administration may affect thrombotic/inflammatory status and endothelial function in patients with T2DM and coronary artery disease (CAD). Methods: Fifty-five patients with T2DM + CAD (26 insulin-treated (INS) and 29 under oral biguanide + sulphonylurea (TABL)) were recruited. Endothelial function was assessed by gauge-strain plethysmography, and serum levels of inflammatory and thrombotic markers were determined by enzyme linked immunosorbent assay. Results: There was no significant difference in endothelium-dependent dilation (EDD) between the study groups, while EDD was correlated with fasting glucose levels in both INS (r = -0.776, p = 0.0001) and TABL (r = -0.702, p = 0.0001). Patients in INS group had higher levels of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha), monocyte chemoattractant protein (MCP-1) and vascular cell adhesion molecule (sVCAM-1), compared to TABL. However, TNF-alpha was negatively correlated with protein C (PrtC) only in INS (r = -0.726, p = 0.01) but not in TABL group (r = -0.066, p = 0.738). Similarly, sVCAM-1 was correlated with PrtC only among INS patients (r = -0.45 1, p = 0.046) but not in TABL (r = 0.069, p = 0.727). In multivariate analysis, insulin dependence was a predictor of IL-6, TNF-u, MCP-1 and sVCAM-1 levels independently from the patients' demographic characteristics, the angiographic extend of CAD or the duration of diabetes. Conclusions: Insulin treatment in patients with type 2 diabetes mellitus affects the expression of inflammatory cytokines and subsequently modifies the thrombotic mechanisms in patients with coronary atherosclerosis, independently from the duration of diabetes and the extend of coronary artery disease.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 27 条
[11]  
HARRIS M, 1979, DIABETES, V28, P1039
[12]   Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone [J].
Harte, A ;
McTernan, P ;
Chetty, R ;
Coppack, S ;
Katz, J ;
Smith, S ;
Kumar, S .
CIRCULATION, 2005, 111 (15) :1954-1961
[13]   Inflammatory pathways and insulin action [J].
Hotamisligil, GS .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (Suppl 3) :S53-S55
[14]   DECREASED EFFECT OF INSULIN TO STIMULATE SKELETAL-MUSCLE BLOOD-FLOW IN OBESE MAN - A NOVEL MECHANISM FOR INSULIN RESISTANCE [J].
LAAKSO, M ;
EDELMAN, SV ;
BRECHTEL, G ;
BARON, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1844-1852
[15]   RANDOMIZED TRIAL OF INSULIN-GLUCOSE INFUSION FOLLOWED BY SUBCUTANEOUS INSULIN-TREATMENT IN DIABETIC-PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION (DIGAMI STUDY) - EFFECTS ON MORTALITY AT 1 YEAR [J].
MALMBERG, K ;
RYDEN, L ;
EFENDIC, S ;
HERLITZ, J ;
NICOL, P ;
WALDENSTROM, A ;
WEDEL, H ;
WELIN, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (01) :57-65
[16]   Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus [J].
Morishita, E ;
Asakura, H ;
Jokaji, H ;
Saito, M ;
Uotani, C ;
Kumabashiri, I ;
Yamazaki, M ;
Aoshima, K ;
Hashimoto, T ;
Matsuda, T .
ATHEROSCLEROSIS, 1996, 120 (1-2) :7-14
[17]   Insulin treatment and cardiovascular disease; friend or foe? A point of view [J].
Muis, MJ ;
Bots, ML ;
Grobbee, DE ;
Stolk, RP .
DIABETIC MEDICINE, 2005, 22 (02) :118-126
[18]   Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control -: Results from the pioneer study [J].
Pfützner, A ;
Marx, N ;
Lübben, G ;
Langenfeld, M ;
Walcher, D ;
Konrad, T ;
Forst, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (12) :1925-1931
[19]   Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality -: The 22-year follow-up results of the Helsinki Policemen Study [J].
Pyörälä, M ;
Miettinen, H ;
Laakso, M ;
Pyörälä, K .
DIABETES CARE, 2000, 23 (08) :1097-1102
[20]   NITRIC-OXIDE RELEASE ACCOUNTS FOR INSULINS VASCULAR EFFECTS IN HUMANS [J].
SCHERRER, U ;
RANDIN, D ;
VOLLENWEIDER, P ;
VOLLENWEIDER, L ;
NICOD, P .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2511-2515